Endursed by


Home > Welcoming note
.: Welcoming note

Stroke is a life-threatening disease with a significant impact on mortality and morbidity. It is recognized as the third cause of death and leading cause of morbidity in developed countries causing a severe economic burden.  Stroke patients in the Middle East and Central Asia regions are believed to be younger and have a higher rate of mortality as compared to those in the Western countries. Therefore,there is an urgent need for the neurologists in these regions of the world to gain more knowledge of and experience with both prevention and treatment strategies pertaining to stroke. Moreover,it is crucial for policymakers to allocate more resources to deal with this disease within these regions.

It is our pleasure to announce that the Clinical Neurology Research Center at Shiraz University of Medical Sciences will host the 2nd International Iranian Stroke Congress in Shiraz,Iran,from September 23rd to 25th,2015. Iran is situated in the crossroads of civilizations in the Middle East and Central Asia,and Shiraz is the capital of art and culture in the region. Several international keynote lecturers from prestigious American and European academic institutions will present their experiences in the treatment of cerebrovascular disease and stroke throughout the conference.

On behalf of the organizing committee,we look forward to seeing you for the Stroke Congress in Shiraz.


M.H Imanieh MD
Chancellor of Shiraz university of Medical Sciences

Co-Secretary Generals:

A.Shariat MD


A. Borhani-Haghighi MD


"Head of executive committee": A. Nikseresht "Neurosonology Workshop" Moderator: M. Pourjafar "Interventional Neurology Workshop" Moderator: B. Vararipour "Botulinum Injection Workshop" Moderator: P. Petramfar

Ladies and Gentlemen,

On behalf of the scientific and organizing committees it is my pleasure to invite you to participate to the 2nd International Iranian Stroke Congress in Shiraz,Iran,from September 23rd to 25th,2015. This conference focused on novel advances in research in the field of cerebrovascular disease. First-time incidence of stroke occurs almost 17 million times a year worldwide; one every two seconds. Stroke continues to be the second leading cause of death worldwide and accounts for about 1 in 10 deaths or 5.7 million deaths a year. Globally,over the past 4 decades,stroke incidence rates have fallen by 42% in high-income countries and increased by >100% in low- and middle-income countries. There is substantial variation in the distribution of stroke burden by geographic region and by country—the level that may be most relevant for policy and program development.
Unfortunately,it seems that stroke prevalence and mortality rate in Iran are higher than the global rate. Demographic and vascular risk factor trends suggest that there will be an even greater burden of disease from stroke in coming years and will represent a major public health challenge moving forward. This concentration of stroke burden suggests that a targeted approach for addressing stroke in the developing world may be warranted.
Such congresses is an outstanding opportunity to share our knowledge to find scientific solution and improve burden of disease for stroke. We aimed this congress fulfill the expectations of the audiences and organizers in that a number of emerging concepts will be presented and discussed.
I wish all of you a pleasant and productive time.


  Hossein Pakdaman
Professor of Neurology
President of the Iranian Neurological Association